Conditions:   Type 2 Diabetes;   Gastric Banding
Interventions:   Drug: Liraglutide;   Drug: Orlistat;   Drug: Liraglutide + Orlistat
Sponsors:   East Carolina University;   East Carolina University
Not yet recruiting - verified May 2012

Condition:   Morbid Obesity
Interventions:   Drug: Ephedrine sulfate with caffeine;   Drug: cellulose
Sponsors:   Oregon Weight Loss Surgery, LLC;   Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012

Condition:   Cigarette Smoking
Interventions:   Drug: Nicotine replacement therapy - transdermal nicotine patch;   Behavioral: Tailored behavioral intervention;   Behavioral: Tobacco quitline referral;   Drug: Nicotine replacement therapy - nicotine gum;   Drug: Nicotine replacement therapy - nicotine lozenge;   Drug: Bupropion SR;   Drug: Varenicline;   Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine gum;   Drug: Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge;   Drug: Combination pharmacotherapy - transdermal nicotine patch + bupropion;   Behavioral: Alcohol use risk reduction;   Behavioral: Behavioral activation for the treatment of depression;   Behavioral: Behavioral management of post-cessation weight gain
Sponsors:   University of Iowa;   University of Iowa;   Department of Veterans Affairs
Not yet recruiting - verified May 2012

Condition:   Obesity
Intervention:   Drug: Tigecycline
Sponsors:   Albany College of Pharmacy and Health Sciences;   Albany College of Pharmacy and Health Sciences
Recruiting - verified March 2012

Conditions:   Overactive Bladder;   Overactive Urinary Bladder
Interventions:   Drug: MK-4618;   Drug: Tolterodine ER;   Drug: MK-1468 and Tolterodine ER;   Other: Placebo (MK-4618);   Other: Placebo (Tolterodine ER);   Drug: Prophylactic Antibiotic
Sponsors:   Merck;   Merck
Recruiting - verified February 2012

Conditions:   Migraine;   Migraine Disorders;   Headache
Interventions:   Drug: Amitriptyline;   Drug: Topiramate;   Drug: Placebo
Sponsors:   Children's Hospital Medical Center, Cincinnati;   Children's Hospital Medical Center, Cincinnati;   National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting - verified April 2012

Condition:   Triclosan Effects on Microbial Flora.
Intervention:   Other: triclosan/triclocarban-containing personal care products
Sponsors:   Stanford University;   Stanford University
Recruiting - verified January 2012

Condition:   Polycystic Ovary Syndrome
Interventions:   Drug: Salsalate;   Drug: Salsalate
Sponsors:   Indiana University;   Indiana University
Recruiting - verified February 2012

Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Closed loop with pramlintide;   Device: Closed loop without pramlintide;   Drug: Open loop with pramlintide
Sponsors:   University of Virginia;   University of Virginia;   The Paul Manning Foundation (private)
Recruiting - verified September 2011

Condition:   Cyanotic Congenital Heart Disease
Interventions:   Drug: Topiramate;   Other: No medication, but routine heart surgery
Sponsors:   University of California, Davis;   University of California, Davis
Recruiting - verified August 2011

Conditions:   Alcohol Dependence;   Alcoholism;   Alcohol Abuse;   Alcohol Use Disorder;   PTSD;   Posttraumatic Stress Disorder
Interventions:   Drug: Topiramate;   Drug: Placebo
Sponsors:   University of Maryland;   University of Maryland;   Department of Veterans Affairs
Not yet recruiting - verified August 2011

Conditions:   Obesity;   Phentermine Withdrawal
Intervention:   Drug: Abrupt cessation of phentermine pharmacotherapy
Sponsors:   Center for Weight Management, California;   Center for Weight Management, California;   American Society of Bariatric Physicians
Recruiting - verified August 2011

Conditions:   Hyperandrogenemia;   Polycystic Ovary Syndrome;   Obesity
Interventions:   Drug: Dexamethasone;   Drug: Cortrosyn
Sponsors:   University of Virginia;   University of Virginia;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   University of California, San Diego
Recruiting - verified August 2011

Conditions:   Leukemia;   Lymphoma;   HIV
Interventions:   Drug: Fludarabine and Busulfan (Flu/Bu);   Drug: Fludarabine and Melphalan (Flu/Mel);   Drug: Busulfan and Fludarabine (Bu/Flu);   Drug: Cyclophosphamide and Total Body Irradiation (Cy/TBI);   Drug: Fludarabine;   Drug: Busulfan, Fludarabine, Cyclophosphamide
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Network
Recruiting - verified March 2012

Conditions:   Obesity;   Metabolic Syndrome X
Interventions:   Drug: Metformin;   Drug: Orlistat;   Drug: Topiramate;   Drug: Placebo
Sponsors:   University of Iowa;   University of Iowa
Recruiting - verified April 2012

Condition:   Chronic Rhinitis
Interventions:   Drug: Placebo;   Drug: Guaifenesin
Sponsors:   Virginia Commonwealth University;   Virginia Commonwealth University;   Pfizer
Recruiting - verified May 2011

Condition:   Urinary Bladder, Overactive
Interventions:   Drug: MK-4618 low-dose;   Drug: MK-4618 mid-low dose;   Drug: MK-4618 mid-high dose;   Drug: tolterodine ER;   Drug: Placebo for MK-4618;   Drug: Placebo for tolterodine ER;   Drug: MK-4618 high dose
Sponsors:   Merck;   Merck
Recruiting - verified May 2012

Condition:   Overactive Bladder
Interventions:   Drug: Tolterodine ER;   Drug: Placebo
Sponsors:   Pfizer;   Pfizer
Recruiting - verified May 2012

Conditions:   Asthma;   Obesity;   Inflammation
Interventions:   Drug: Montelukast;   Drug: Placebo;   Drug: Montelukast;   Drug: Placebo
Sponsors:   North Shore Long Island Jewish Health System;   North Shore Long Island Jewish Health System;   Thrasher Research Fund;   Merck
Recruiting - verified January 2012

Conditions:   Obesity;   Mycoses
Intervention:   Drug: Anidulafungin
Sponsors:   Texas Tech University Health Sciences Center;   Texas Tech University Health Sciences Center;   National Center for Research Resources (NCRR);   University of Texas Southwestern Medical Center
Recruiting - verified October 2011

Condition:   Type 1 Diabetes
Interventions:   Drug: Pramlintide;   Drug: Exenatide;   Drug: Insulin
Sponsors:   Albert Einstein College of Medicine of Yeshiva University;   Albert Einstein College of Medicine of Yeshiva University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2012

Condition:   Obesity
Interventions:   Dietary Supplement: IHBG-10;   Dietary Supplement: Placebo
Sponsors:   Avera McKennan Hospital & University Health Center;   Avera McKennan Hospital & University Health Center
Not yet recruiting - verified January 2011

Condition:   Obesity
Interventions:   Other: Placebo;   Dietary Supplement: IHBG-10
Sponsors:   Avera McKennan Hospital & University Health Center;   Avera McKennan Hospital & University Health Center
Not yet recruiting - verified January 2011

Conditions:   Alcohol Dependence;   Nicotine Dependence
Interventions:   Drug: Topiramate with brief behavioral enhancement therapy;   Drug: Placebo plus brief behavioral enhancement therapy
Sponsors:   University of Virginia;   University of Virginia;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   M.D. Anderson Cancer Center;   University of California, San Diego
Recruiting - verified March 2012

Conditions:   Obesity;   Pharmacokinetics;   MRSA;   Tuberculosis;   PCP
Intervention:   Drug: Sulfamethoxazole/trimethoprim
Sponsors:   Texas Tech University Health Sciences Center;   Texas Tech University Health Sciences Center;   National Center for Research Resources (NCRR);   University of Texas Southwestern Medical Center
Recruiting - verified February 2012

Conditions:   Obesity;   Leprosy;   Tuberculosis
Intervention:   Drug: Dapsone
Sponsors:   Texas Tech University Health Sciences Center;   Texas Tech University Health Sciences Center;   National Center for Research Resources (NCRR)
Recruiting - verified February 2012

Conditions:   Pain;   Obesity
Interventions:   Drug: Lidocaine Infusion;   Drug: Normal Saline
Sponsors:   Northwestern University;   Northwestern University
Recruiting - verified May 2012

Conditions:   Cannabis Abuse;   Cannabis Dependence
Interventions:   Drug: Topiramate;   Drug: Placebo
Sponsors:   Brown University;   Brown University;   National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011

Conditions:   C-reactive Protein;   Inflammation;   Obesity;   Oxidative Stress
Intervention:   Dietary Supplement: Vitamin C (ascorbic acid)
Sponsors:   University of California, Berkeley;   University of California, Berkeley;   Kaiser Permanente
Recruiting - verified June 2011

Condition:   Idiopathic Intracranial Hypertension
Interventions:   Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
Sponsors:   St. Luke's-Roosevelt Hospital Center;   St. Luke's-Roosevelt Hospital Center;   National Eye Institute (NEI);   University of Rochester;   University of Iowa;   University of California, Davis
Recruiting - verified May 2012

Condition:   Lower Urinary Tract Symptoms
Interventions:   Drug: dutasteride 0.5 mg, used with tolterodine ER 4mg or placebo;   Drug: dutasteride
Sponsors:   Siami, Paul F., M.D.;   Siami, Paul F., M.D.;   GlaxoSmithKline;   Pfizer
Recruiting - verified July 2011

Conditions:   Alcoholism;   Alcohol Dependence;   Alcohol Abuse
Interventions:   Drug: topiramate;   Drug: zonisamide;   Drug: Levetiracetam;   Drug: Placebo
Sponsors:   Boston Medical Center;   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified May 2011

Conditions:   Obesity;   Binge Eating
Interventions:   Behavioral: Behavioral Weight Loss;   Behavioral: Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy;   Drug: Placebo;   Drug: Sibutramine
Sponsors:   Yale University;   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012

Condition:   Polycystic Ovary Syndrome
Interventions:   Drug: Orlistat (Alli) and Lifestyle Intervention with exercise and diet;   Drug: Loestrin 1/20;   Drug: Orlistat (Alli) and Loestrin 1/20
Sponsors:   Penn State University;   Penn State University;   University of Pennsylvania
Recruiting - verified November 2011

Condition:   Psoriasis
Interventions:   Procedure: Narrow band (310-312 nm) ultraviolet light B phototherapy;   Drug: etanercept
Sponsors:   University of California, San Francisco;   University of California, San Francisco
Recruiting - verified February 2012

Condition:   Alcohol Drinking
Interventions:   Drug: topiramate;   Drug: placebo
Sponsors:   University of Connecticut Health Center;   University of Connecticut Health Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Center for Research Resources (NCRR)
Recruiting - verified December 2011

Condition:   Sleep-Related Eating Disorder
Intervention:   Drug: Topiramate or Placebo
Sponsors:   Brigham and Women's Hospital;   Brigham and Women's Hospital
Recruiting - verified July 2011

Conditions:   Obesity;   Binge Eating
Interventions:   Drug: Sibutramine;   Drug: Placebo;   Behavioral: Self-help CBT + Sibutramine;   Behavioral: Self-help CBT + Placebo
Sponsors:   Yale University;   Yale University;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012

Conditions:   Psoriasis;   Metabolic Syndrome;   Hyperlipidemia;   Obesity;   Hypertension
Intervention:   Drug: Etanercept
Sponsors:   Massachusetts General Hospital;   Massachusetts General Hospital;   Amgen
Recruiting - verified February 2012

Conditions:   Alcohol Dependence;   Cocaine Dependence
Interventions:   Drug: Topiramate + Cognitive Behavioral Therapy;   Drug: Placebo + Cognitive Behavioral Therapy
Sponsors:   University of Virginia;   Bankole Johnson;   National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012

Conditions:   OBESITY;   HYPERTENSION;   PURE AUTONOMIC FAILURE;   SHY-DRAGER SYNDROME
Interventions:   Drug: Trimethaphan;   Drug: Trimethaphan;   Drug: Pseudoephedrine
Sponsors:   Vanderbilt University;   Vanderbilt University
Recruiting - verified May 2012

Condition:   Alcoholism
Interventions:   Drug: ondansetron + cognitive behavioral therapy;   Drug: topiramate + cognitive behavioral therapy;   Drug: Placebo + cognitive behavioral therapy;   Drug: ondansetron + topiramate + cognitive behavioral therapy
Sponsors:   University of Virginia;   Bankole Johnson;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified February 2012